Back to News
Market Impact: 0.18
Epitel’s REMI Neuro Monitoring System Selected for the FDA’s READI-Home Innovation Challenge
Source: Business Wire
Healthcare & BiotechTechnology & Innovation
Epitel will engage with the FDA to explore home-use applications for its REMI wireless EEG system, aimed at extended-duration neurological monitoring. The initiative could expand REMI's use in epilepsy and other remote-monitoring settings, but no approval, timeline, or financial impact was disclosed.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.35
More News
- Wall Street’s Nasdaq hits all-time high as AI frenzy gathers pace
- Data-Center Bet Makes ESDS One of India’s Best New Listings
- Asia stocks ride tech wave higher, oil stays subdued
- U.S. regulators rush to write crypto rulebook after Clarity Act stalls in Senate
- Meta is breaking out after introducing Muse AI agent. Where the stock is going, according to the charts
- Heidi CEO on AI in Healthcare, $900M valuation